Opening book details…
Can I read Catalogue record on EtoBox?
Catalogue record is a nonfiction available to read on EtoBox.
What is Catalogue record about?
DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer 1 1 Introduction 1 2 Materials and methods 2 2.1 Reagents and antibodies 2 2.2 Tissue microarray and immunohistochemistry (IHC) 2 2.3 Cell lines, culture, and cell stress assay 2 2.4 Small interfering RNA, plasmid, and vector construction 2 2.5 Transfection and establishment of stable cell lines 2 2.6 Transwell, colony formation, and apoptosis assays 2 2.7 Western blot assay and co-immunoprecipitation assay 3 2.8 Quantitative real-time PCR (qPCR) 3 2.9 Ubiquitination assay 3 2.10 Mass spectrum analysis 3 2.11 Animal study 3 2.12 Public database and bioinformatics analysis 3 2.13 Statistical analysis 4 3 Results 4 3.1 DAB2IP was positively associated with an improved prognosis of colon cancer in patients expressing wild-type p53 4 3.2 DAB2IP exerted tumor-suppressive effects and increased wild-type p53 protein levels in colon cancer cells 4 3.3 DAB2IP inhibited the degradation of p53 in a ubiquitin-proteasome-dependent manner 4 3.4 DAB2IP interacted with the ubiquitin ligase-related protein GRP75 7 3.5 DAB2IP suppressed p53 ubiquitination through competitive antagonism towards GRP75 7 3.
Who reads Catalogue record?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Language
- UND
- Category
- nonfiction
Similar books
- RNA Demethylase ALKBH5 Suppresses Tumorigenesis via Inhibiting Proliferation And
- Artesunate Inhibits PDE4 Leading to Intracellular cAMP Accumulation, Reduced ERK
- The UCHL5 Inhibitor b-AP15 Overcomes Cisplatin Resistance via Suppression of Can
- Labyrinthin: A Distinct Pan-adenocarcinoma Diagnostic and Immunotherapeutic Tumo
- UBE4B Promotes the Development of Lung Adenocarcinoma by Enhancing Proliferation
- PHLDB2 Mediates Cetuximab Resistance via Interacting With EGFR in Latent Metasta